Remove Amortization Remove Legal Remove Prospects
article thumbnail

Could the Biden Administration's Latest Move Send Aurora Cannabis Stock Soaring?

The Motley Fool

has gotten investors even more bullish about the stock and its long-term prospects. It has been reducing the scale of its operations to become leaner, while also focusing on the medicinal market -- which would likely be legalized before the recreational market. Legalization in the U.S. million Canadian dollars.

Legal 246
article thumbnail

The Best Cannabis Stock to Invest $1,000 in Right Now

The Motley Fool

One thing you should know off the bat is that marijuana legalization isn't inevitable in the U.S., Unlike Tilray's Irwin Simon and Canopy's David Klein, who are often on investing shows talking up their growth prospects, odds are you probably haven't even seen Bachtell or heard of him. They're also burning through tons of cash.

Legal 189
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Aurora Cannabis Is Having a Good Year in 2024. Has It Turned Its Business Around?

The Motley Fool

This is why many cannabis companies focus on their adjusted earnings before interest, taxes, depreciation, and amortization ( EBITDA ) numbers. There are some encouraging opportunities, such as in Germany, where the country recently legalized cannabis for personal use. million Canadian dollars ($1.4 once they open up.

article thumbnail

This 5.1%-Yielding Dividend Stock Makes a $2 Billion Acquisition to Add More Fuel to Its Dividend Growth Engine

The Motley Fool

It recently added more fuel to its growth engine by making a $2 billion acquisition that will supply it with incremental cash flow while enhancing its growth prospects. The company is paying about 10 times estimated 2024 earnings before interest, taxes, depreciation, and amortization ( EBITDA ) for these assets. billion to $6.8

Prospects 246
article thumbnail

Should You Invest in Aurora Cannabis Stock in 2024?

The Motley Fool

Aurora reported an adjusted earnings before interest, taxes, depreciation, and amortization ( EBITDA ) profit of CA$3.4 But with cannabis investors losing heavily on pot stocks in recent years and no progress on marijuana legalization in the U.S., legalization efforts. million last quarter. the optimism has faded.

Investing 189
article thumbnail

Why AstraZeneca Stock Is Sliding Today

The Motley Fool

Its core EPS, which excludes costs related to the amortization of intangibles, impairments, legal settlements, and restructuring charges, fell 8% to $1.98. Several pharma stocks offer better growth prospects, more attractive valuations, and higher dividend yields than AstraZeneca does. Is AstraZeneca stock a buy?

article thumbnail

Is Aurora Cannabis Stock a Buy Now?

The Motley Fool

It also reported a record adjusted earnings before interests, taxes, depreciation, and amortization ( EBITDA ) of CA$3.4 Aurora's prospects are uncertain One of the reasons behind Aurora Cannabis's poor results in recent years is that the recreational cannabis market in Canada has been a mess. Its revenue of 63.4

Legal 130